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Abstract
The expression of 4 pluripotency genes (Oct4, Sox2, c-Myc and Klf4) in mouse embryonic
fibroblasts can reprogramme them to a pluripotent state. We have investigated the expression of
these pluripotency genes when human somatic 293T cells are permeabilised and incubated in
extracts of mouse embryonic stem (ES) cells. Expression of all 4 genes was induced over 1 - 8
hours. Gene expression was associated with loss of repressive histone H3 modifications and
increased recruitment of RNA polymerase II at the promoters. Lamin A/C, which is typically
found only in differentiated cells, was also removed from the nuclei. When 293T cells were
returned to culture after exposure to ES cell extract, the expression of the pluripotency genes
continued to rise over the following 48 hours of culture, suggesting that long-term reprogramming
of gene expression had been induced. This provides a methodology for studying the de-
differentiation of somatic cells that can potentially lead to an efficient way of reprogramming
somatic cells to a pluripotent state without genetically altering them.
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INTRODUCTION
Reprogramming of differentiated somatic cells into pluripotent cell is a promising approach
for regenerative medicine. The ability to reprogram somatic cells was first demonstrated in
mammals by the generation of animals after nuclear transfer [1-3] and secondly by the
derivation of embryonic stem cells (ES) from the inner cell mass (ICM) cells of SCNT
embryos [4]. It has also been reported that embryonic stem (ES) cells, embryonal carcinoma
(EC) cells and embryonic germ (EG) cells can induce nuclear reprogramming after
hybridisation with somatic cells [5-8].
In a different approach Takahashi et al [9] showed that when over-expressed in mouse
embryonic fibroblasts (MEFs), 4 genes (Oct4, Sox2, c-Myc and Klf4) could induce the
morphology and growth properties of embryonic stem (ES) cells. The DNA methylation,
gene expression and chromatin state of these induced pluripotent stem (iPS) cells were also
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similar to those of ES cells [9-12]. Further, iPS cells could form viable chimaeras, including
contribution to the germ line [10-12]. Similar results have recently been reported for somatic
cells [13-16]. These results suggest that to successfully re-programme somatic cells,
expression of only these 4 genes is needed.
It would be advantageous to develop reprogramming methods that do not alter the genetic
content of the reprogrammed cells. One approach used by Collas and co-workers is to
transiently permeabilize the plasma membrane of cells with streptolysin-O (SLO), after
which the membrane can spontaneously reseal so that cells can continue growth in culture
[17]. When differentiated SLO-permeabilised cells were briefly incubated in ES cell extracts
and then returned to cell culture for several weeks, colonies were obtained that had been
stably reprogrammed to express a range of pluripotency genes [18, 19]. One drawback of
these studies is that it is difficult to estimate the efficiency of reprogramming because the
successive changes of medium leads to a selection for proliferating cells. Long incubations
in culture also make it more time-consuming to analyse systematically factors involved in
the reprogramming of gene expression.
In this paper, we have examined changes that occur directly after exposure of SLO-
permeabilized somatic cells to ES cell extract. We demonstrate that the induction of the 4
key pluripotency genes (Oct4, Sox2, c-Myc and Klf4) can be detected within a few hours of
ES cell treatment. This opens up a range of in vitro approaches to analysing biochemical
mechanisms involved in the de-differentiation of somatic cells and that could ultimately lead
to the development of new methods for efficiently reprogramming somatic cells.
MATERIALS AND METHODS
Cells
NCCIT and 293T (American Type Culture Cells, ATCC) were cultured in RPMI 1640
medium (Invitrogen) with 10% fetal calf serum (FCS), 2 mM L-glutamine, 1 mM sodium
pyruvate, nonessential amino acids (complete RPMI 1640 medium) and 1% penicillin/
streptomycin. NIH 3T3 (ATCC) were cultured in DMEM (Invitrogen) with 4.5 g/L L-
glucose, 4 mM L-glutamine, 10% FCS, 1.5 g/L sodium bicarbonate and 1% penicillin/
streptomycin. Mouse 46C and J1 ESCs (ATCC) were cultured in GMEM (Invitrogen) with
10% FCS, 2 mM sodium pyruvate, 0.1 mM β-mercaptoethanol, non essential amino acids,
1% penicillin/Streptomycin and 1000 U/ml (10 ng/ml) recombinant leukaemia inhibitory
factor (LIF; Sigma) on gelatine-coated plates. MEFs (from CD1 foetuses, used at passage
number 3 or 4) were cultured in DMEM with 10% FCS and 1% penicillin/streptomycin.
Cells treated with extracts were seeded at 100,000 cells per well in a 24-well plate and
cultured in 500 μl of complete RPMI 1640 medium with antibiotics.
Cell Extracts
To prepare ES or 3T3 cell extracts, cells were washed twice in PBS and once in cell lysis
buffer (20 mM HEPES pH 8.2, 50 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol, 0.1 mM
phenylmethylsulfonyl fluoride (PMSF) and 0.1% protease inhibitor cocktail (Sigma),
sedimented at 400xg, resuspended in 0.8 vols cold cell lysis buffer and incubated 45 min on
ice. Cells were sonicated on ice in 2 ml aliquots using a Soniprep 150 sonicator fitted with a
3-mm-diameter probe (MSE) until all cells and nuclei were lysed, as judged by microscopy.
The lysate was cleared at 15,000xg for 15 min at 4°C and the supernatant frozen in beads
with 2% glycerol and stored in liquid nitrogen. One bead of extract was used to determine
protein concentration (∼30 mg/m) and pH (∼7.0).
Activated Xenopus egg extract was prepared as described [20]. Oocyte extract was prepared
from ovaries rinsed in Barth buffer (88 mM NaCl, 2 mM KCl, 1 mM MgCl2, 15 mM Tris-
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HCl pH 7.6, 0.5 mM CaCl2) and digested 6 hours at room temperature in 5 volumes OR-2
buffer (82 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 5 mM HEPES pH 7.5) containing 0.2%
collagenase type I (Sigma) with occasional agitation. Stage 4-6 oocytes were then selected
on size, washed 4x in Barth buffer and 2x in extraction buffer (50 mM KCl, 50 mM HEPES,
pH 7.4, 5 mM MgCl2, 2 mM β-mercaptoethanol) and prepared as for egg extracts. Xenopus
extracts contained 40 - 60 mg/ml protein.
SLO-permeabilization and cell extract treatment
Cells were washed 2x in PBS, 1x in cold Acetate Buffer (115 mM KO Acetate, 25 mM
HEPES pH 7.4, 2.5 mM KCl) and were incubated for 50 min in Acetate Buffer + 10 mM
DTT + 1.5 μg/ml pre-activated SLO at 1000 cells/μl at 37°C with occasional agitation.
Permeabilization was assessed by monitoring uptake of Trypan Blue (Invitrogen).
After permeabilization, cells were resuspended at 1000 cells/μl in 100 μl cell extracts
containing 2 mM ATP, 10 mM creatine phosphate, 25 μg/ml creatine kinase; Sigma), 1.1
mM GTP, 1 mM of both CTP and UTP (Roche Diagnosis), 50 μg/ml ampicillin and 15 μg/
ml fungin (optionally supplemented with 100 μM α-amanitin or 1 mg/ml cycloheximide)
and incubated at 37°C (23°C for Xenopus extracts) in a H2O bath with occasional agitation.
For membrane resealing, extract was diluted with 1 ml RPMI 1640 + 2 mM CaCl2, and
incubated for 2 hr at 37°C in a H2O bath. Cells were pelleted through 100 μl sterile HBSS
(Invitrogen) containing 10% sucrose at 400xg in a swinging bucket centrifuge for 5 min at
4°C. Pelleted cells was resuspended in 1 ml RPMI 1640 and seeded on 24-well plates. After
culture, both floating and adherent cells were collected for analysis.
Real-time Reverse Transcription (RT)-PCR
Total RNA was isolated using a Qiagen RNeasy Mini kit with a DNaseI treatment during the
purification and eluted in 35 μl DEPC-treated water. RT was performed with 8 μl total RNA
using the Superscript First-Strand synthesis System (Invitrogen) and random hexamers.
Quantitative RT-PCR reactions were performed in triplicates on an IQ5 real-time PCR
detection system (BioRad). SYBR Green PCR conditions were 95°C for 5 min and 40
cycles of 95°C for 15 s, 60°C or 58°C for 10 s and 72°C for 20 s using Lamin B2 as
standard. Primers and conditions are described in Supplementary Figure S1.
Chromatin Immunoprecipitation
Cells were fixed in 1 ml 1% formaldehyde, 50 mM Hepes, 50 mM KCl, 5 mM MgCl2, 2
mM DTT, protease inhibitors, pH 7.5 and pelleted through 10% sucrose and resuspended in
1% SDS, 10 mM EDTA, 50 mM Tris, pH 8, plus protease inhibitors. Following incubation
on ice for 10 min, chromatin was sheared by sonication (Misonix microson XL2000) with
5×10 s bursts at 7-8W and with >1 min on ice between bursts. Insoluble material was
pelleted at 13,000xg for 5 min and supernatant was diluted 10x with ChIP dilution buffer
(0.01% SDS, 1.1% Triton X-100, 167 mM NaCl, 1.2 mM EDTA, 16.7 mM Tris, pH 8).
Supernatant was precleared for 1 hour with salmon sperm DNA plus Protein A (Upstate
16-157C). Chromatin from 2×105 cells was incubated overnight at 4°C with antibodies,
which were collected with 50 μl Protein A beads, and washed (low salt wash: 150 mM
NaCl, 0.1% SDS, 1% Triton, 2 mM EDTA, 20 mM Tris, pH 8; high salt wash: as low salt
wash except 500 mM NaCl; LiCl buffer: 0.25M LiCl, 1% NP-40, 1% sodium deoxycholate,
1 mM EDTA, 10 mM Tris, pH 8; TE: 1 mM EDTA, 10 mM Tris, pH 8) and eluted in 400 μl
1% SDS, 0.1 M sodium bicarbonate for 30 min at room temperature. Formaldehyde cross-
links were reversed in 0.2 M NaCl, 4 hours at 65°C. Proteins were degraded with proteinase
K (40 μg/ml plus 40 mM Tris, 10 mM EDTA pH 8, at 45°C, 1 hr) and DNA was recovered
by phenol/chloroform extraction (using Eppendorf LPG tubes) and ethanol precipitation (0.1
M sodium acetate pH 5.8, 2 μg glycogen). Pellets were resuspended in 40 μl water. Usually,
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1 μl was used for PCR reactions. The quantity of DNA used for the PCR was first titrated to
find a range where the PCR signal is semi-quantitative, and then samples were normalised to
levels of GAPDH.
Antibodies
ChIP antibodies: Histone H3-K4 trimethylated (Upstate, MC315 05-745), histone H3-K9
acetylated (Upstate, 07-352), histone H3-K9 dimethylated (Upstate, 07-441), histone H3-K9
trimethylated (Upstate, 07-442), histone H3-K27 dimethylated (Upstate, 07-452), histone
H3-K27 trimethylated (Upstate, cat no. 07-449), RNA polymerase II (Santa Cruz, sc-899X;
used at 10-20 μg/IP). Upstate antibodies were used at 2-5 μg/IP. Western Blot and
Immunofluorescence antibodies: Lamin A/C antibody used at 1/1000 for
immunofluorescence (Eurogentec, MUB1102) and 1/2500 for western blot (Santa Cruz);
Lamin B1 antibody (Santa Cruz, sc-6217) used at 1/300 for immunofluorescence and 1/2500
for western blot; Oct4 antibody (Santa Cruz) at 1/1000; and Nanog antibody (Chemicon) at
1/10000.
Immunofluorescence
MEFs attached to 6 mm 10-well slides (VWR) were washed 2x with PBS, once with Acetate
Buffer then incubated in SLO for 50 mins at 37°C as described above. Permeabilisation
buffer was aspirated and cells were covered with 40 μl extract and incubated for 3 hours at
23°C for Xenopus egg extract or 37°C for ES cell extract. Cells were gently washed with
PBS, fixed in 4% formaldehyde/PBS for 20 mins, permeabilised with 0.2% Triton for 10
mins and blocked with 2% BSA for 1 hr. Incubations of primary antibodies were carried out
overnight at 4°C. Secondary antibodies were FITC-conjugated anti-mouse antibody for
Lamin A and Cy-3-conjugated anti-goat antibody for Lamin B.
RESULTS
Removal of lamin A/C from somatic cells by ES cell extracts
Lamin A/C is a major component of the nuclear lamina that is expressed in differentiated but
not in pluripotent cells (Figure 1A). Lamin A/C can be removed from permeabilised somatic
cells by incubation in extracts of oocytes or eggs of the frog Xenopus laevis [21]. We
investigated the ability of ES cell extracts to remove lamin A/C from permeabilised MEFs.
Figure 1B and C show that extracts prepared from 46C mouse ES cell extract removed lamin
A/C from nuclei in >55% of MEF cells. In contrast, the levels of lamin B, which is
expressed in both ES and somatic cells, remained constant. The degree of lamin A/C
removal was comparable to that seen with Xenopus egg extract. Similar to results with
Xenopus extracts [21], when ATP was depleted from the ES cell extract by addition of
apyrase, the percentage of cells undergoing lamin A/C removal was strongly reduced. This
suggests that nuclear lamin remodelling is an energy-dependent process and can be
promoted by extracts prepared from mouse ES cells.
ES cell extracts promote pluripotency-associated gene expression
We next investigated whether mouse ES cell extracts could induce somatic cells to induce
transcription of genes associated with pluripotency. Using real time PCR we showed that, as
expected, the mRNA levels of the pluripotency-associated genes Oct4, Nanog, Sox2, c-Myc
and Klf4 was higher in human undifferentiated embryonal carcinoma cells (NCCIT) than in
differentiated human embryonic kidney 293T cells (Figure 2A). In contrast, the lamin A
gene (LMNA) was down-regulated in NCCIT cells (Figure 2A). Lamin B2 (LMNB2),
ubiquitously expressed in all cells, was used as normalization control. The primers we used
were designed to be specific for the human genes, and were predicted not to amplify their
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mouse homologues. This specificity was confirmed by the absence of amplification of
cDNAs from mouse ES or 3T3 cells (Figure 2A). Using a different set of primers capable of
amplifying the mouse homologues of these genes we observed low expression levels of the
pluripotency genes in somatic 3T3 cells (derived from embryonic fibroblasts) compared
with high levels in 2 pluripotent mouse ES cell lines, 46C and J1 (Figure 2B).
We next optimised the SLO treatment of 293T cells to give ∼80% cell permeabilization
(Supplementary Figure S2) and verified that this allowed the incorporation of both 10 kDa
and 70 kDa dextrans (data not shown). Consistent with previous reports [17, 19], the
majority of cells appeared viable after this treatment, and were capable of forming colonies.
This therefore provided a mechanism for exposing differentiated cell nuclei to extracts with
reprogramming potential, and then returning the cells to culture.
After SLO-permeabilization, 293T cells were incubated in extracts of mouse 46C or J1 ES
cells. Using the human specific primers, we detected the induction of Oct4, Klf4, Nanog,
Sox2 and c-Myc mRNA during the 8 hr of incubation (Figure 2C and D). In contrast,
expression of LMNA, normally down-regulated in ES cells, remained stable. All PCR
products were verified by restriction digestion to confirm that expression of the human
genes was occurring (Supplemental Figure S3). As negative control we also showed that
incubation of permeabilized 293T cells in somatic 3T3 cell extract caused no significant
change in expression of the pluripotency genes (Figure 2E). Further, no significant change in
gene expression was observed in non-permeabilised 293T cells after incubation in ES cell
extract (Figure 2F).
Since Xenopus egg and oocyte extracts can remove lamin A/C from somatic nuclei (Figure
1 and [21]), we also investigated whether they could induce expression of pluripotency
genes in permeabilised 293T cells. After permeabilization with SLO, 293T cells were
exposed for 0 to 8 hours to either Xenopus egg (Figure 3A) or oocyte (Figure 3B) extracts.
In contrast to ES cell extracts, no significant change of expression was observed for any of
our pluripotency marker genes (Oct4, Nanog, Sox2, c-Myc, Klf4) or for LMNA.
One possible explanation for the inactivity of Xenopus extracts is that one or more factors
involved in the reprogramming process is unable to recognise a key target in human cells.
To test this, mixtures with different ratios of mouse ES and Xenopus oocytes extracts were
used to treat permeabilised 293T cells. Figure 3C shows that, consistent with our previous
experiments, ES cell extract induced the expression of Nanog, Oct4, Sox2, c-Myc and Klf4.
As the ES extract was replaced with Xenopus oocyte extract, the expression of all these
genes declined. We therefore obtained no evidence that Xenopus oocyte extracts provide
any stimulation of the activity provided by the mouse ES cell extract.
ES cell extracts induce RNA polymerase II binding at Nanog and Oct4 promoters
The binding of RNA polymerase II to a promoter is an essential step in the commitment to
initiate transcription. We used chromatin immunoprecipitation (ChIP) to analyse the loading
of RNA polymerase II onto promoters of pluripotency genes (Figure 4A and B). This
revealed a modest increase in binding of RNA polymerase II at the Nanog and Oct4
promoters. Increased loading of RNA polymerase was also detected on the promoter of the
Cripto gene, which is also specifically expressed in undifferentiated cells [22]. Induction of
pluripotency genes was blocked by addition to the 46C ES cell extract of α-amanitin, an
inhibitor of RNA polymerase II (Figure 4C). Taken together, these results strongly suggest
that a range of pluripotency genes are induced when permeabilised 293T cells are of
incubated in ES cell extract.
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Figure 4C also shows that addition of cycloheximide, an inhibitor of protein synthesis, to the
ES cell extracts reduced the efficiency by which gene expression was induced. One possible
explanation for this is that translation of key transcriptional regulators is rapidly induced
during the incubation of somatic cells in ES cell extracts and is necessary for efficient
activation of pluripotency genes.
Mouse ES cell extracts modify histone H3 on promoters of pluripotency genes
The post-translational modification of histone N termini, most notably on histone H3, plays
a key role in regulating transcriptional activation or repression of genes [23, 24]. We used
antibodies against acetylated and methylated lysines on histone H3 to perform ChIP on 293T
cells before and after exposure to ES extracts. Figure 5A shows that the Nanog and Cripto
promoters in pluripotent NCCIT cells had more acetylated H3K9 and trimethylated H3K4,
typically associated with active promoters, than the same promoters in 293T cells.
Conversely, dimethylated H3K9, which is typically associated with a repressed chromatin
state, was more abundant on Nanog and Oct4 promoters in 293T than NCCIT cells.
Trimethylated H3K27, also typically associated with a repressed chromatin state, was more
abundant on the Cripto and Oct4 promoters in 293T cells than NCCIT cells. All these
differences are consistent with higher activity of the Nanog, Oct4 and Cripto promoters in
NCCIT cells [18]. In contrast, no significant differences were detected between NCCIT and
293T cells for any histone H3 modification on the GAPDH promoter.
Treatment of 293T cells with 46C ES cell extract reduced the methylation of H3K9 (Figure
5C) and H3K27 (Figure 5D) on the Oct4 promoter and reduced methylation of H3K9 on the
Nanog promoter (Figure 5C), consistent with them becoming de-repressed. There was also
slight reduction in the methylation of H3K9 and H3K27 on the Cripto promoter. In contrast,
there was little evidence for the appearance of the activating chromatin modifications,
trimethylated H3K4 and acetylated H3K9 on these promoters (Figure 5B). Some transient
changes were detected to the level of these modifications but were not maintained. These
results suggest that treatment of somatic nuclei with ES cell extract lowers the level of
certain repressive chromatin modifications, but does not strongly induce activating
modifications. This is consistent with a partial chromatin remodelling that might be
sufficient to allow the regulatory regions of some pluripotency genes to recruit RNA
polymerase II.
The expression of pluripotent marker genes increases after treatment
To determine whether exposure to ES cell extract elicits a long-term induction of pluripotent
genes, 293T cells were incubated in 46C ES cell extract for 6 hours, resealed and returned to
cell culture. The level of marker gene expression was quantified by real time PCR after 16,
21, 41 or 48 hours in culture. Figure 6 shows the abundance of the different mRNA levels
normalised to the abundance in untreated 293T cells. Over the whole 48 hours in culture, a
continued up-regulation was observed for Nanog, Oct4, Sox2, c-Myc and Klf4 genes (note
log scale). LMNA levels showed no significant changes over this period of time. The
continued and increasing expression of pluripotency genes suggests that exposure of 293
nuclei to ES cell cytoplasm can induced a long-term induction of gene expression that drives
the cells towards a more pluripotent state.
DISCUSSION
This study provides insight into the molecular changes that take place during
reprogramming of gene expression in mammalian somatic cells exposed to ES cell extracts
and establishes a new approach for the identification of the active factors involved in this
process. Exposure of transiently permeabilised human epithelial 293T cells to mouse ES cell
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extract induced loss of lamin A/C, activation of pluripotency gene expression and histone
modification at the promoters of activated genes. These effects were maintained, and in fact
increased, after treated cells were returned to culture, suggesting that long-term
reprogramming of gene expression in the somatic cells had occurred.
In our experiments, 293T cells were permeabilized using SLO, after which cell membranes
can reseal and cells can continue to grow in culture [17]. Consistent with work by Taranger
et al [19] but in contrast to a separate report [25] we saw no induction of gene expression in
the absence of membrane permeabilization. Genes that were up-regulated included Klf4,
Oct4, Sox2 and c-Myc. It has recently been shown that forced expression of these genes in
adult mouse fibroblasts is sufficient to turn them into pluripotent stem cells [9-12]. The
changes that we have induced are therefore likely to have started to drive the epithelial 293T
cells towards full pluripotency. We also observed up-regulation of Nanog, which along with
Oct4 has been shown to function as a core transcription factor in maintaining pluripotency
[26, 27]. Consistent with these changes being due to an induction of transcriptional activity,
we detected increased RNA polymerase II binding to the promoters and showed that mRNA
expression was inhibited by α-amanitin, an inhibitor of RNA polymerase II.
After exposure of 293T cells to mouse ES cell extract for 1 to 8 hours, a steady up-
regulation of expression of pluripotency genes was observed. When the membranes were
allowed to reseal and treated cells were returned to culture, the expression levels of
pluripotency genes continued to rise over the following 48 hours, suggesting that long-term
reprogramming of gene expression had occurred. The induction of Klf4 (∼70-fold) and c-
Myc (∼12-fold) approached that of ES cells. However, induction of Sox2 (∼7-fold), Oct4
(∼6-fold) and Nanog (∼24-fold) was still significantly lower than the ∼200-fold, ∼250-fold
and ∼1000-fold observed in the ES cells. This suggests that full reprogramming to a
pluripotent state had not been achieved, but that exposure to ES cell extract had initiated a
series of changes driving the somatic cells towards a more pluripotent state. Consistent with
this interpretation, we observed chromatin changes over pluripotency gene promoters
suggestive of a loss of transcriptional repression (demethylation of H3K9 and, to a lesser
extent, of H3K27) but not of strong transcriptional activation (acetylation of H3K9 or
methylation of H3K4). Similarly, although ES cell extracts reduced levels of lamin A/C
protein in the permeabilized 293T cells, we did not observe a significant decrease in the
expression of the LMNA gene as would be expected of pluripotent cells [19].
Microinjection of somatic cells into living Xenopus oocyte nuclei induces Oct4 gene
expression and promoter demethylation after a period of 2 days [28-30]. We therefore
investigated whether Xenopus egg and oocyte extracts could also induce pluripotency gene
expression in permeabilised 293T cells. Unfortunately, we observed no induction of
pluripotency genes relative to expression levels of housekeeping genes and in addition, no
stimulation of gene expression was observed when Xenopus egg extract was supplemented
with different quantities of ES cell extract. Our results are in contrast to the work of Hansis
et al [25], who exposed digitonin-treated cells to Xenopus extract for 30 minutes and
observed reprogramming of Oct4 expression after four days in media. We were unable to
repeat this result (data not shown).
Our results build upon the work of Collas and colleagues who also used extracts of ES cells
to reprogram SLO-permeabilized somatic cells [18, 19, 31]. In these studies, treated cells
were grown out in culture for several weeks, after which cells could be identified that had
been stably reprogrammed to express pluripotency genes. Freberg et al [18] also reported
chromatin changes similar to the ones we report here. Because there is a long period of
culture involved in this procedure, it is hard to determine the efficiency of reprogramming as
an unknown proportion of the original somatic cells will be retained in culture. A second
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disadvantage of this protocol is that the long culture time means that experiments are
relatively slow, making further biochemical analysis of the ES cell extracts hard to perform.
Our study demonstrates that the first stages of reprogramming do not depend on long-term
culture and occur during short incubations. One limitation of the current study is that we
have only investigated the response of one particular cell line (293T cells) to ES cell
cytoplasm. Further work to validate this approach needs to determine the range of cell types
that will respond in similar ways. This could open up a range of further in vitro approaches
to study biochemical mechanisms involved in this process. We assayed changes in the total
population of treated somatic cells and did not remove non-adherent cells when we returned
the cells to culture. The extent to which we observe induction of pluripotency genes is
therefore likely to represent a minimum value, since if only a proportion of permeabilized
cells responded to the ES extract after treatment, the real level of expression of marker genes
in these cells will have been under-estimated. Our approach provides a way of analysing
features of the reprogramming process by, for example, fractionating the ES cell extracts to
identify the factors involved activities. Use of such activities could eventually lead to an
efficient way of reprogramming somatic cells to a pluripotent state without genetically
altering them.
Supplementary Material
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Figure 1.
Removal of lamin A/C from cells incubated in ES cell or Xenopus egg extracts.
(A) Western blot of Nanog, Oct4, Lamin A/C and Lamin B in MEF and 46C ES cells. (B,
C) MEF cells were permeabilized and incubated in 46C ES cell extract or Xenopus egg
extract for 3 hours in plus or minus apyrase. Cells were then stained for lamin A/C (FITC,
green), lamin B2 (Cy-3, red) or DNA (DAPI, blue). Quantification in (C) was performed by
visual inspection. Scale bar, 5μm.
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Figure 2.
Activation of pluripotency genes in permeabilized 293T cells exposed to mouse ES cell
extracts.
(A, B) Quantitative RT-PCR analysis of indicated genes in EC or ES cells relative to
differentiated 293T or 3T3 cells. In A, human specific-primers were used, whilst in B,
primers recognising both human and mouse genes were used. NA - no amplification. (C-F)
Quantitative RT-PCR analysis using human-specific primers of gene expression in 293T
cells treated for 0 to 8 hours with: (C, F) mouse J1 ES cell extract, (D) mouse 46C ES cell
extract and (E) mouse 3T3 cell extract. In (F), unpermeabilised 293 cells were used.
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Figure 3.
Absence of reprogramming activity in Xenopus egg or oocyte extracts.
Quantitative RT-PCR analysis of expression of indicated genes in 293T cells treated for 0 to
8 hours with: (A) Xenopus egg extract, (B) Xenopus oocyte extract or (C) mixes of ES cell
and Xenopus oocyte extracts for 6 hours.
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Figure 4.
Efficient induction of pluripotency genes depends on transcription and translation.
(A, B) Chromatin immunoprecipitation, using an RNA polymerase II antibody, on either
untreated NCCIT or 293 cells (A) or 293T cells incubated in 46C ES cell extract for 0 to 6
hours (B). Chromatin immunoprecipitates were subjected to PCR using primers specific for
GAPDH, Nanog (promoter 1), Oct4 and CRIPTO. W, water only control for PCR reaction.
The Nanog promoter (C) Quantitative RT-PCR analysis after incubation of 293T cells for 6
hours in mouse 46C ES extract. The ES extract was optionally supplemented with 100 μM
α-amanitin or 1 mg/ml cycloheximide at the start of the incubation. Expression is expressed
relative to untreated 293T cells.
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Figure 5.
46C ES cell extract induces histone modifications at pluripotency gene promoters.
Chromatin immunoprecipitation was performed on (A) NCCIT and 293T cells or (B-D) on
permeabilized 293T cells exposed to mouse ES cell extract for 0, 2, 4 or 6 hr. Chromatin
was precipitated with antibodies to histone H3 modifications and DNA was amplified using
primers against GAPDH, Nanog (promoter 2), Oct4 and CRIPTO. W, water only control for
PCR reaction. In B-D, input DNA and chromatin precipitated with non-immune IgG
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Figure 6.
Reprogrammed gene expression increases after return to cell culture.
Human 293T cells were permeabilized with SLO and incubated for 6 hours in 46C ES cell
extract. Cell membranes were then allowed to reseal for 2 hours, and the cells were returned
to tissue culture medium. At the indicated times afterwards, quantitative RT-PCR was
performed on selected genes. Expression was normalised to the level of lamin B2 expression
and is expressed relative to levels in untreated 293T cells. Error bars show the standard
deviation from 3 replicates.
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